Skip to main content
. 2019 May 20;10:10–31. doi: 10.1016/j.eclinm.2019.04.006

Fig. 4.

Fig. 4

Cost-effectiveness measures of TasP interventions.

Data points reflect the measures from TasP studies reporting cost per HIV infection averted (above) and cost per DALY averted (below). Points represent study-specific cost-effectiveness estimates; error bars represent estimate ranges, if provided in study results.